Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Jiuda Zhao"'
Autor:
Hengheng Zhang, Guoshuang Shen, Ping Yang, Meijie Wu, Jinming Li, Zitao Li, Fuxing Zhao, Hongxia Liang, Mengting Da, Ronghua Wang, Chengrong Zhang, Jiuda Zhao, Yi Zhao
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background The incidence of autoimmune diseases and breast cancer is significantly higher in women compared to men. Previous observational studies have not conclusively determined the relationship between these two conditions. This study uti
Externí odkaz:
https://doaj.org/article/3b9e270aa8f34e3198eaf4fd7422d6e3
Autor:
Qiao Li, Dan Lv, Xiaoying Sun, Mengyuan Wang, Li Cai, Feng Liu, Chenghui Li, Jiuda Zhao, Jing Sun, Yehui Shi, Fei Ma
Publikováno v:
Cancer Innovation, Vol 3, Iss 5, Pp n/a-n/a (2024)
Abstract Background We explored the efficacy and safety of inetetamab combined with sirolimus and chemotherapy for the treatment of human epidermal factor receptor 2 (HER2)‐positive metastatic breast cancer patients with abnormal activation of the
Externí odkaz:
https://doaj.org/article/6cff81cea58240268e3dd6e588e6951c
Autor:
Zhilin Liu, Jinming Li, Fuxing Zhao, Dengfeng Ren, Zitao Li, Yongzhi Chen, Shifen Huang, Zhen Liu, Yi Zhao, Miaozhou Wang, Huihui Li, ZhengBo Xu, Guoshuang Shen, Jiuda Zhao
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Triple-negative breast cancer (TNBC) is a life-threatening subtype of breast cancer with limited treatment options. Therefore, this network meta-analysis (NMA) aimed to evaluate and compare the effect of various neoadjuvant chemot
Externí odkaz:
https://doaj.org/article/6e906f96b27a4da7816719ae8f1bdf3b
Autor:
Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 2, Iss 2, Pp 81-90 (2024)
Background: Metastatic triple-negative breast cancer (mTNBC) is an aggressive histological subtype with poor prognosis. Several first-line treatments are currently available for mTNBC. This study conducted a network meta-analysis to compare these fir
Externí odkaz:
https://doaj.org/article/6439a61dbb12443393dd4799432f75d1
Autor:
Yongxin Li, Xinlong Tao, Yinyin Ye, Yuyao Tang, Zhengbo Xu, Yaming Tian, Zhen Liu, Jiuda Zhao
Publikováno v:
Cancer Innovation, Vol 3, Iss 6, Pp n/a-n/a (2024)
Abstract Background Young breast cancer (YBC) is a subset of breast cancer that is often more aggressive, but less is known about its prognosis. In this study, we aimed to generate nomograms to predict the overall survival (OS) and breast cancer‐sp
Externí odkaz:
https://doaj.org/article/fb6b3c9bddbd4205a17a440efbe32a6c
Autor:
Jinming Li, Guoshuang Shen, Zhen Liu, Yaobang Liu, Miaozhou Wang, Fuxing Zhao, Dengfeng Ren, Qiqi Xie, Zitao Li, Zhilin Liu, Yi Zhao, Fei Ma, Xinlan Liu, Zhengbo Xu, Jiuda Zhao
Publikováno v:
Cancer Innovation, Vol 2, Iss 5, Pp 346-375 (2023)
Abstract Background The wide use of antibody‐drug conjugates (ADCs) is transforming the cancer‐treatment landscape. Understanding the treatment‐related adverse events (AEs) of ADCs is crucial for their clinical application. We conducted a meta
Externí odkaz:
https://doaj.org/article/75fdfea5bfbf420fa818fa7fc294863f
Autor:
Lizhi Ning, Yaobang Liu, Yujin Hou, Miaozhou Wang, Mingqiang Shi, Zhen Liu, Jiuda Zhao, Xinlan Liu
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 1, Iss 4, Pp 253-261 (2023)
Background: On average, 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) in these patients. Methods: The nomogram was based on
Externí odkaz:
https://doaj.org/article/96147ff2e3cd4eb5a09962f089dc0bce
Autor:
Shujuan Sun, Xiaochu Man, Dongdong Zhou, Fangchao Zheng, Jiuda Zhao, Xuesong Chen, Tong Liu, Jie Huang, Qiaorui Tan, Na Li, Huihui Li
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18850-18860 (2023)
Abstract Purpose The prognostic outcomes of metastasis patterns in patients with de novo metastatic breast cancer (dnMBC) of different ages are unknown. Our study used a large‐scale data to investigate the metastasis patterns and prognostic feature
Externí odkaz:
https://doaj.org/article/ca4a699ff48842588a123bd7d463f894
Autor:
Zhoujuan Li, Guoshuang Shen, Mingqiang Shi, Yonghui Zheng, Yumei Guan, Yuanfang Xin, Miaozhou Wang, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 1, Iss 3, Pp 205-215 (2023)
Background: A high body mass index (BMI) can indicate overweight or obesity and is a crucial risk factor for breast cancer survivors. However, the association between high BMI and prognosis in early-stage breast cancer (EBC) remains unclear. We aimed
Externí odkaz:
https://doaj.org/article/f2ed5ea842fe49c7a69ad1cde2cff7cd
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20407- (2023)
Glucose oxidase (GOx) can specifically catalyze the conversion of β-d-glucose into gluconic acid and hydrogen peroxide (H2O2) in the presence of oxygen, making it promising for tumor starvation therapy and oxidative therapy. However, GOx's immunogen
Externí odkaz:
https://doaj.org/article/e136d6cb5d224fa384e072efc20d570d